These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 16355342)

  • 1. HIV-associated lipoatrophy: what are the kinder, gentler agents?
    Dubé MP
    Clin Infect Dis; 2006 Jan; 42(2):281-2. PubMed ID: 16355342
    [No Abstract]   [Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor gamma agonists and the treatment of HIV-associated lipoatrophy: unraveling the molecular mechanism of their shortcomings.
    Hadigan C
    J Infect Dis; 2008 Dec; 198(12):1729-31. PubMed ID: 18954262
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of zidovudine in development of lipoatrophy.
    Moyle GJ
    AIDS Read; 2005 Nov; 15(11):591-4, 599-600, 603. PubMed ID: 16329181
    [No Abstract]   [Full Text] [Related]  

  • 4. HIV and insulin resistance in context.
    Kotler DP
    AIDS Read; 2005 May; 15(5):220. PubMed ID: 15900630
    [No Abstract]   [Full Text] [Related]  

  • 5. What does the term "HIV-associated lipodystrophy" mean?
    Marcason W
    J Am Diet Assoc; 2009 Feb; 109(2):364. PubMed ID: 19167963
    [No Abstract]   [Full Text] [Related]  

  • 6. [Stigmatization, metabolic trouble, drug resistance: current challenges in HIV therapy].
    Mauss S; Jablonowski H
    MMW Fortschr Med; 2009 Apr; 151(18):28. PubMed ID: 19769068
    [No Abstract]   [Full Text] [Related]  

  • 7. High prevalence of lipoatrophy among patients on stavudine-containing first-line antiretroviral therapy regimens in Rwanda.
    van Griensven J; De Naeyer L; Mushi T; Ubarijoro S; Gashumba D; Gazille C; Zachariah R
    Trans R Soc Trop Med Hyg; 2007 Aug; 101(8):793-8. PubMed ID: 17467756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disorders of body fat distribution in HIV-1-infected patients.
    Moreno S; Miralles C; Negredo E; Domingo P; Estrada V; Gutiérrez F; Lozano F; Martínez E
    AIDS Rev; 2009; 11(3):126-34. PubMed ID: 19654854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stavudine in antiretroviral therapy: is this the end?
    Brinkman K
    AIDS; 2009 Aug; 23(13):1727-9. PubMed ID: 19571724
    [No Abstract]   [Full Text] [Related]  

  • 10. HIV-associated lipodystrophy: a review of underlying mechanisms and therapeutic options.
    Mallewa JE; Wilkins E; Vilar J; Mallewa M; Doran D; Back D; Pirmohamed M
    J Antimicrob Chemother; 2008 Oct; 62(4):648-60. PubMed ID: 18565973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Side effects of antiretroviral therapy--skin manifestations].
    Esser S
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():8, 10-1. PubMed ID: 19024907
    [No Abstract]   [Full Text] [Related]  

  • 12. Pathogenesis and treatment of lipodystrophy: what clinicians need to know.
    Sattler FR
    Top HIV Med; 2008; 16(4):127-33. PubMed ID: 18838747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial comment: correcting facial lipoatrophy has little to do with vanity.
    Wohl DA
    AIDS Read; 2005 Jul; 15(7):372. PubMed ID: 16044580
    [No Abstract]   [Full Text] [Related]  

  • 14. [How to minimize the secondary effects of antiretrovirals].
    Cernadas R
    Sidahora; 2003; (1):8-17. PubMed ID: 12733497
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term complications of antiretroviral therapy: lipoatrophy.
    Waters L; Nelson M
    Int J Clin Pract; 2007 Jun; 61(6):999-1014. PubMed ID: 17504362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention and therapy of HIV-associated lipodystrophy syndrome and antiretroviral caused metabolic changes].
    Mauss S
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():49-53. PubMed ID: 16385875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression and immunohistochemistry in adipose tissue of HIV type 1-infected patients with nucleoside analogue reverse-transcriptase inhibitor-associated lipoatrophy.
    Sievers M; Walker UA; Sevastianova K; Setzer B; Wågsäter D; Eriksson P; Yki-Järvinen H; Sutinen J
    J Infect Dis; 2009 Jul; 200(2):252-62. PubMed ID: 19519254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buffalo hump in HIV patients: surgical management with liposuction.
    Sharma D; Bitterly TJ
    J Plast Reconstr Aesthet Surg; 2009 Jul; 62(7):946-9. PubMed ID: 18468504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of lipoatrophy on patient-reported outcomes in antiretroviral-experienced patients.
    Doward LC; Dietz B; Wilburn J; McKenna SP; Bhor M; Rajagopalan R
    AIDS Read; 2008 May; 18(5):242-6, 252-6, 262-4. PubMed ID: 18589480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV lipodystrophy: where are we after ten years?
    Vergel N
    GMHC Treat Issues; 2007; 21(3-4):10-5. PubMed ID: 19230305
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.